Oral Human Papillomavirus Infection in HIV-infected Men

Sponsor
Deutsche Luft und Raumfahrt (Other)
Overall Status
Unknown status
CT.gov ID
NCT00421486
Collaborator
(none)
500
2
142.1
250
1.8

Study Details

Study Description

Brief Summary

Human papillomavirus (HPV)-infection belong to the most common sexually transmitted diseases worldwide. HIV-infected men having sex with men /MSM) are strongly associated with a higher prevalence of genitoanal HPV-infection, and perianal HPV-infections have been detected in up to 90% of HIV-positive men. The data concerning the incidence of oral HPV-infection in HIV-positive men, especially in the era of highly antiretroviral therapy, are conflicting. Thus, this prospective study mainly focuses on the incidence and prevalence of oral HPV-infection, spectrum of HPV-types, and oral high-risk HPV viral load in HIV-positive men.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Oral swabs for HPV-typing and high-risk HPV-determination

Detailed Description

Human papillomavirus (HPV)-infection belong to the most common sexually transmitted diseases worldwide. Estimated prevalences of subclinical genital HPV-infection in the immunocompetent sexually active population range from 10 to above 50%. Genetic or iatrogenic immunosuppression is known to play a decisive role in the initiation of a variety of cutaneous neoplasias and their precursor lesions. In this context, HPV-associated anogenital malignancies occur with high frequency in patients with HIV-infection. In several studies, perianal HPV-infections have been detected in up to 90% of HIV-positive men and a high incidence of anal dysplasia has been reported in these patients. The data concerning the incidence of oral HPV-infection in HIV-positive men, especially in the era of highly antiretroviral therapy, are conflicting. Thus, this prospective study mainly focuses on the incidence and prevalence of oral HPV-infection, spectrum of HPV-types, and oral high-risk HPV viral load in HIV-positive men.

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Incidence, Prevalence, Spectrum of HPV-types, and Viral Load Determination of High-risk Human Papillomavirus Infection of the Oral Cavity in HIV-infected Men Who Have Sex With Men
Study Start Date :
Mar 1, 2006
Anticipated Primary Completion Date :
Jan 1, 2017
Anticipated Study Completion Date :
Jan 1, 2018

Outcome Measures

Primary Outcome Measures

  1. Spectrum of HPV types and associated clinical lesions [swabs will be obtained approximately every 6 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • HIV-infected men who have sex with men
Exclusion Criteria:
  • None

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Dermatology, Ruhr University Bochum Bochum NRW Germany 44791
2 Institute of Virology, University of Cologne Köln NRW Germany 50935

Sponsors and Collaborators

  • Deutsche Luft und Raumfahrt

Investigators

  • Principal Investigator: Alexander Kreuter, MD, Department of Dermatology, Ruhr University Bochum
  • Principal Investigator: Norbert Brockmeyer, MD, Department of Dermatology, Ruhr University Bochum
  • Principal Investigator: Ulrike Wieland, MD, Institute of Virology, University of Cologne

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Alexander Kreuter, Prof. Dr., Deutsche Luft und Raumfahrt
ClinicalTrials.gov Identifier:
NCT00421486
Other Study ID Numbers:
  • 01 KI 0501
First Posted:
Jan 12, 2007
Last Update Posted:
Jan 21, 2016
Last Verified:
Jan 1, 2016

Study Results

No Results Posted as of Jan 21, 2016